Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:

Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2020-02-18
Sale
Apellis Pharmaceuticals, Inc.APLSFrancois Cedric
Chief Executive Officer, Director
35,637$40.66$1,449,000
2020-02-14
Sale
Apellis Pharmaceuticals, Inc.APLSMachiels Alec
Director
2,500$42.35$105,875
2020-02-13
Sale
Apellis Pharmaceuticals, Inc.APLSDeschatelets Pascal
Chief Operating Officer
55,398$40.98$2,270,210
2020-02-12
Sale
Apellis Pharmaceuticals, Inc.APLSDeschatelets Pascal
Chief Operating Officer
52,075$42.80$2,228,810
2020-02-10
Sale
Apellis Pharmaceuticals, Inc.APLSWatson David O.
General Counsel
5,000$44.50$222,500
2020-01-27
Sale
Apellis Pharmaceuticals, Inc.APLSWatson David O.
General Counsel
3,000$40.47$121,410
2020-01-15
Sale
Apellis Pharmaceuticals, Inc.APLSMachiels Alec
Director
2,500$41.47$103,675
2020-01-15
Sale
Apellis Pharmaceuticals, Inc.APLSFrancois Cedric
Chief Executive Officer, Director
35,638$42.11$1,500,716
2020-01-13
Purchase
Apellis Pharmaceuticals, Inc.APLSMorningside Venture Investments Ltd
10% owner
540,540$37.00$19,999,980
2019-12-20
Sale
Apellis Pharmaceuticals, Inc.APLSDunlop A. Sinclair
Director
25,000$29.53$738,250
2019-12-19
Sale
Apellis Pharmaceuticals, Inc.APLSDunlop A. Sinclair
Director
85,110$29.18$2,483,509
2019-12-18
Sale
Apellis Pharmaceuticals, Inc.APLSDunlop A. Sinclair
Director
25,890$28.55$739,159
2019-12-16
Sale
Apellis Pharmaceuticals, Inc.APLSFrancois Cedric
Chief Executive Officer, Director
5,000$27.95$139,750
2019-11-15
Sale
Apellis Pharmaceuticals, Inc.APLSFrancois Cedric
Chief Executive Officer, Director
5,000$27.28$136,400
2019-10-15
Sale
Apellis Pharmaceuticals, Inc.APLSFrancois Cedric
Chief Executive Officer, Director
5,000$26.31$131,550
2019-09-25
Sale
Apellis Pharmaceuticals, Inc.APLSDeschatelets Pascal
Chief Operating Officer
21,541$25.26$544,125
2019-09-24
Sale
Apellis Pharmaceuticals, Inc.APLSDeschatelets Pascal
Chief Operating Officer
21,602$24.58$530,977
2019-09-23
Sale
Apellis Pharmaceuticals, Inc.APLSDeschatelets Pascal
Chief Operating Officer
20,858$25.07$522,910
2019-09-16
Sale
Apellis Pharmaceuticals, Inc.APLSFrancois Cedric
Chief Executive Officer, Director
5,000$26.59$132,950
2019-08-29
Purchase
Apellis Pharmaceuticals, Inc.APLSSullivan Timothy Eugene
Chief Financial Officer
11,699$29.71$347,577
2019-08-15
Sale
Apellis Pharmaceuticals, Inc.APLSFrancois Cedric
Chief Executive Officer, Director
10,000$26.80$268,000
2019-03-11
Purchase
Apellis Pharmaceuticals, Inc.APLSMorningside Venture Investments Ltd
10% owner
441,176$17.00$7,499,992
2018-09-21
Purchase
Apellis Pharmaceuticals, Inc.APLSMorningside Venture Investments Ltd
10% owner
40,000$19.84$793,600
2018-09-20
Purchase
Apellis Pharmaceuticals, Inc.APLSMorningside Venture Investments Ltd
10% owner
41,323$19.13$790,508
2018-09-19
Purchase
Apellis Pharmaceuticals, Inc.APLSMorningside Venture Investments Ltd
10% owner
60,000$18.09$1,085,400
2018-09-18
Purchase
Apellis Pharmaceuticals, Inc.APLSMorningside Venture Investments Ltd
10% owner
40,000$18.47$738,800
2018-09-17
Purchase
Apellis Pharmaceuticals, Inc.APLSMorningside Venture Investments Ltd
10% owner
40,000$18.57$742,800
2018-09-14
Sale
Apellis Pharmaceuticals, Inc.APLSWatson David O.
General Counsel
15,776$18.78$296,273
2018-05-24
Purchase
Apellis Pharmaceuticals, Inc.APLSSCHEIBLER LUKAS
See Remarks
2,935$20.37$59,785
2017-11-13
Purchase
Apellis Pharmaceuticals, Inc.APLSMorningside Venture Investments Ltd
10% owner
575,000$14.00$8,050,000
2017-11-13
Purchase
Apellis Pharmaceuticals, Inc.APLSvenBio Global Strategic Fund II L.P.
10% owner
127,515$14.00$1,785,210
2017-11-13
Purchase
Apellis Pharmaceuticals, Inc.APLSHillhouse Capital Management, Ltd.
10% owner
1,428,571$14.00$19,999,994
2017-11-13
Purchase
Apellis Pharmaceuticals, Inc.APLSCormorant Asset Management, LLC
10% owner
1,071,428$14.00$14,999,992

1

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*